Daniel Troy Nrx Pharmaceuticals, Inc. (NRXP) insider trading activity
Daniel Troy is Director of NRX Pharmaceuticals, Inc.. Currently has a direct ownership of 43,093 shares of NRXP, which is worth approximately $65,070. The most recent transaction as insider was on May 24, 2021, when has been sold 43,093 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
43.1K
0%
3M change
0%
12M change
Total Value Held
$65,070
DT
Daniel Troy
Director
Wilmington, DE